Covidien ETCO2

Evaluating ETCO2 as a sixth vital sign, which will improve patient care and Correlation of ETCO2 with patient outcomes including mortality, hospital admission, ICU admission and vasopressor use

August 09, 2017

  • Clinical Trial Information

    Trial Contact: Silvestri, Salvatore MD

    Trial Phone:

  • Age Group: Adult

    Phase: Not applicable

    Principal Investigator: Jay G. Ladde, MD

    Sub Investigators: N/A

    IRB No: 15.012.02

    Secondary Protocol No:

    Applicable Disease Sites: None